12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0.347. It has been cited 8 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0173
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
NIH
Grant: R03 TR003381,R41 DK122917,R01 DK10558,U01 DK127786,T32 AI153020
Breakthrough T1D
Grant: 3-PDF-2023-1326-A-N
Diabetes Research Connection
Grant: DRC-51
Veralox Therapeutics
Grant: VLX-100
Chicago Biomedical Consortium
Grant: Director’s Award
NIDDK NIH HHS
Grant: P30 DK020595
NIDDK NIH HHS
Grant: U01 DK127786
NIDDK NIH HHS
Grant: R41 DK122917
NIDDK NIH HHS
Grant: T32 DK007011
NCATS NIH HHS
Grant: R03 TR003381
NIDDK NIH HHS
Grant: R01 DK060581
NIDDK NIH HHS
Grant: R01 DK105588
NIAID NIH HHS
Grant: T32 AI153020
FWCI
3.00
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals